Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Jonathan E. Lim

Jonathan E. Lim

individual
Capital ownerFund operatorEcosystem influencer

About

Jonathan E. Lim, M.D., is a physician-turned biotech entrepreneur and investor best known as chairman, CEO and co-founder of Erasca. He previously co-founded and led Ignyta through its sale to Roche, served as CEO of Halozyme, and has also held investing roles as Managing Partner of City Hill and Venture Partner at ARCH Venture Partners. His record centers on precision oncology, RAS/MAPK biology, and company creation in biotech.

Areas of interest

biotechprecision oncologycancer therapeuticsRAS/MAPK biologydrug deliveryventure investingcompany building